iRhythm Holdings Appoints UnitedHealth Group Executive Jason Patten to Board

summarizeSummary

iRhythm Holdings has appointed Jason Patten, Executive Vice President at UnitedHealth Group, to its Board of Directors and Audit Committee, bringing significant strategic leadership and healthcare industry expertise.

check_boxKey Events

• New Director Appointed

  Jason Patten, Executive Vice President and Head of Enterprise Strategy at UnitedHealth Group, was appointed to iRhythm's Board of Directors and Audit Committee, effective March 12, 2026.

• Strategic Expertise Added

  Mr. Patten brings decades of strategic leadership in healthcare, including experience in corporate strategy, strategic partnerships, and innovation, which is expected to support iRhythm's growth and operational excellence.

• Director Compensation Details

  Mr. Patten will receive an initial restricted stock unit grant valued at $300,000, vesting over three years, along with an annual cash retainer of $65,000 for his board and audit committee service. He also received a one-time payment of $86,771 for prior advisory services.

auto_awesomeAnalysis

The appointment of Jason Patten, a seasoned executive from UnitedHealth Group with extensive experience in enterprise strategy, partnerships, and innovation, is a positive development for iRhythm Holdings. His background aligns directly with the company's stated goals of scaling operations, expanding profitability, and advancing its platform from episodic detection to proactive care. This strategic addition to the board is expected to provide invaluable guidance as iRhythm focuses on growth, AI capabilities, and market expansion.